To reconcile the seemingly inconsistent results on changes in the proportion and number of macrophages during CRC development, we used the ESTIMATE algorithm and CD45 (PTPRC) immune cell marker to assess immune infiltration levels in NC and CRC tissues (Fig. 4A). The gene discussed is PTPRC; the disease is colorectal carcinoma.